Study identifier:D5980R00117
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Prospective Multicentric Cohort Study of Severe and very Severe COPD patients in Brazil.
COPD (Chronic Obstructive Pulmonary Disease)
Phase 4
No
-
All
693
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2025 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|